Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin

Transfusion Medicine Reviews

Volumn 15, Issue 3, 2001, Pages 213-223

  Strauss, Ronald G ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HUMAN; LOW BIRTH WEIGHT; NEWBORN; PATHOPHYSIOLOGY; PREMATURITY; VERY LOW BIRTH WEIGHT;

EID: 0034883718     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tm.2001.24592     Document Type: Article

References (53)

1. Current issues in neonatal transfusions
2. Anemia of prematurity. Current concepts in the issue of when to transfuse
3. Postnatal changes in erythropoietin levels in untransfused premature infants
4. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity
5. Erythropoietin in the pathogenesis and treatment of neonatal anemia
6. Circulating erythroid progenitors in the anemia of prematurity
7. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with "anemia of prematurity"
8. Erythroid colonies derived from fetal blood display different growth patterns from those derived from adult marrow
9. Studies in the liver to kidney switch of erythropoietin production
10. Erythropoietin mRNA expression in human fetal and neonatal tissue
11. Postnatal changes in serum Ep in relation to hypoxia before and after birth
12. Erythropoietin pharmacokinetics in premature infants: Developmental, nonlinearity, and treatment effects
13. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia
14. Neonatal apnea: Pathogenesis and therapy
15. Blood transfusion effect on the respiratory pattern of preterm infants
16. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs and erythropoietin level
17. Weight gain: A response to transfusion in selected preterm infants
18. The role of RBC transfusion in selected preterm infants
19. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age
20. A method to collect, store and issue multiple aliquots of packed red blood cells for neonatal transfusions
21. Commentary on the safety of red blood cells preserved in extended storage media for neonatal transfusions
22. AS-1 red blood cells for neonatal transfusions: A randomized trial assessing donor exposure and safety
23. Feasibility and safety of AS-3 red blood cells for neonatal transfusions
24. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates
25. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells
26. Reducing donor exposure in preterm infants requiring multiple blood transfusions
27. 2,3-Diphosphoglycerate in normal, anaemic and transfused human fetuses
28. Exchange transfusion in the newborn infant with fresh and "old" blood: The role of storage on a 2,3-diphosphoglycerate, hemoglobin-oxygen affinity, and oxygen release
29. Comparison of two preservation solutions for erythrocyte transfusions in newborn infants
30. Nutricel as an additive solution for neonatal transfusion
31. Randomized trial assessing feasibility and safety of biological parents as red blood cell donors for their preterm infants
32. Cost-effectiveness of a limited donor blood program for neonatal RBC transfusions
33. Recombinant erythropoietin in the treatment of the premature newborn
34. Meta-analysis of controlled clinical trials studying the efficacy of recombinant human erythropoietin in reducing blood transfusions in the anemia of prematurity
35. Erythropoietin - Not yet a standard treatment for anemia of prematurity
36. The role of erythropoietin in the anemia of prematurity
37. Changing patterns of red blood cell transfusions in very low birth weight infants
38. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g
39. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants
40. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity
41. Erythropoietin (Epo), protein and iron supplementation and the prevention of anemia of prematurity: Effects on serum immunoreactive Epo, growth and protein and iron metabolism
42. Enhancement of erythropoiesis by erythropoietin, bovine protein and energy fortified mother's mild during anemia of prematurity
43. Effect of low and moderate doses of recombinant human erythropoietin on the hematological response in premature infants on a high protein and iron intake
44. Erythropoiesis of very low-birth-weight infants dependent on prenatal growth rate and protein status
45. Recombinant erythropoietin for the anemia of prematurity: Still a promise, not a panacea
46. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very-low-birth-weight preterm infants
47. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled trial
48. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very-low-birth-weight infants: A randomized, double-blind, placebo-controlled trial
49. A multi-center randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants
50. Erythropoietin gene expression in human, monkey and murine brain
51. Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses
52. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA
53. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus